DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Asacol (Mesalamine) - Current Clinical Trials

 
 



Asacol Related Clinical Trials

Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I) [Completed]

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis [Recruiting]

Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis [Terminated]

Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis [Completed]

Sulfamethoxazole Drug Interaction Study With MMX� Mesalazine/Mesalamine [Recruiting]

Canadian Active & Maintenance Modified Pentasa Study [Recruiting]

A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease [Completed]

Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis [Recruiting]

The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study [Recruiting]

Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis [Recruiting]

Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis [Recruiting]

Predicting Response to Standardized Pediatric Colitis Therapy [Recruiting]

Efficacy and Safety of Asacolâ„¢ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis [Recruiting]

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis [Recruiting]

A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis. [Completed]

Cimzia Versus Mesalamine for Crohn's Recurrence [Not yet recruiting]

Clinical Trial With Mesalamine 1g Suppositories [Recruiting]

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis [Recruiting]

Mesalazine Treatment in IBS (The MIBS Study) [Recruiting]

Mechanistic Randomized Controlled Trial (RCT) of Mesalazine in Symptomatic Diverticular Disease [Recruiting]

Asacol Dosing Study for Active Ulcerative Colitis [Completed]

Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS) [Recruiting]

Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis [Recruiting]

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis [Completed]

Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis. [Recruiting]

Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis [Recruiting]

Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase [Recruiting]

A Double Blind Study for the Treatment of Acute Ulcerative Colitis [Completed]

TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC) [Not yet recruiting]

CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission [Completed]

The Influence of 5–Aminosalicylates on Thiopurine Metabolite Levels [Completed]

Targeting Oxidative Stress in Chronic Beryllium Disease [Recruiting]

Mesalazine Therapy in Patients With Irritable Bowel Syndrome [Recruiting]

The Colitis Once Daily Asacol Study [Recruiting]

A Study With Pentasa in Patients With Active Crohn's Disease [Recruiting]

Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study) [Recruiting]

Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea [Recruiting]

Asacol Acute Diverticulitis(DIVA)Study [Recruiting]

Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease [Recruiting]

PK Study of Encapsulated Mesalamine Granules in Healthy Volunteers [Active, not recruiting]

A Comparison of Once a Day Dose Compared to 2 Doses/Day [Recruiting]

Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients [Terminated]

Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (Study P05553) [Recruiting]

Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis [Recruiting]

Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis [Recruiting]

Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA [Not yet recruiting]

The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease" [Not yet recruiting]

Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D) [Recruiting]

Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis [Recruiting]

OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis [Completed]

Dose Escalation and Remission (DEAR) [Recruiting]

(CB-01-02/01)Randomized Placebo Controlled Trial of Budesonide-MMXâ„¢ (CB-01-02) 6 mg and 9 mg in Patients With Ulcerative Colitis [Recruiting]

Strategies in Maintenance for Patients Receiving Long-Term Therapy" (S.I.M.P.L.E.) [Recruiting]

Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC) [Recruiting]

Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis [Recruiting]

Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis [Recruiting]

Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission [Completed]

Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476 [Completed]

Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD) [Completed]

Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission [Terminated]

Prevention of Recurrence of Diverticulitis [Recruiting]

Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis [Completed]

Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis [Recruiting]

Mesalamine and Reproductive Health Study [Recruiting]

Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis [Recruiting]

Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis [Completed]

Prevention of Recurrence of Diverticulitis [Recruiting]

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA [Recruiting]

Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis [Recruiting]

Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome [Recruiting]

A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis [Recruiting]

Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis. [Completed]

Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients [Completed]

Fecal Biomarker Study for Patients With Ulcerative Colitis [Recruiting]

SONIC Study of Biologic and Immunomodulator Naive Patients in Crohn's Disease [Active, not recruiting]

A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease [Recruiting]

NICE: Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study [Completed]

Monoclonal Antibody Treatment of Crohn's Disease [Completed]

A Dose-Finding Study of OPC-6535 in Patients With Active Crohn's Disease [Terminated]

Crohn's Disease Stem Cell Transplantation [Recruiting]

A Dose-Finding Study of OPC-6535 in Patients With Active Ulcerative Colitis [Terminated]

Methods of Improvement Adherence With Therapy in Ulcerative Colitis. [Not yet recruiting]

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis [Completed]

Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease [Recruiting]

Phase II Study of HMPL-004 in Patients With Ulcerative Colitis [Recruiting]

The Effect of Infliximab on Sperm Quality [Not yet recruiting]

Randomized Placebo Controlled Trial of Budesonide-MMXâ„¢ 6 mg and 9 mg in Patients With Ulcerative Colitis [Recruiting]

Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis [Completed]

Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis [Suspended]

Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease [Completed]

Alicaforsen (ISIS 2302) in Patients With Active Crohn’s Disease

EPANOVA in Crohn's Disease, Study 1

ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis [Completed]

VSL#3 Treatment in Children With Crohn's Disease [Not yet recruiting]

Hypnotherapy for Prevention of Relapse in Ulcerative Colitis: a Randomised, Single-Blind, Controlled Clinical Trial [Enrolling by invitation]

Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis [Recruiting]

Open-Label, Long-Term Balsalziade Disodium Tablet Ulcerative Colitis Study [Terminated]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012